In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates
- 15 June 2006
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 28 (1), 75-78
- https://doi.org/10.1016/j.ijantimicag.2006.02.011
Abstract
The activity of linezolid was studied against 55 Mycobacterium tuberculosis (42 susceptible, 3 isoniazid resistant and 10 isoniazid and rifampicin resistant), one Mycobacterium bovis and two multidrug-resistant M. bovis isolates using the standard 7H10 agar proportion and the ESP Culture System II methods. Both methods displayed similar MIC90 values (minimum inhibitory concentrations for 90% of the organisms) of 0.5 mg/L; however, the former method yielded slightly lower MIC50 values (MICs for 50% of the organisms) (0.25 mg/L) compared with the latter method (0.5 mg/L). No differences were observed between susceptible and resistant isolates, including multidrug-resistant M. bovis isolates, with a MIC range of 0.12–0.5 mg/L. The potential role of linezolid in tuberculosis patients requires further in vivo evaluation.Keywords
This publication has 23 references indexed in Scilit:
- Linezolid for the treatment of multidrug-resistant tuberculosisJournal of Antimicrobial Chemotherapy, 2005
- Action of Fluoroquinolones and Linezolid on Logarithmic- and Stationary-Phase Culture of Mycobacterium tuberculosisChemotherapy, 2004
- Intrapulmonary penetration of linezolidJournal of Antimicrobial Chemotherapy, 2003
- Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2003
- In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous DrugsAntimicrobial Agents and Chemotherapy, 2003
- In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2002
- Intrapulmonary Pharmacokinetics of LinezolidAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics and Tissue Penetration of Linezolid following Multiple Oral DosesAntimicrobial Agents and Chemotherapy, 2001
- Predictors and Outcome of Multidrug-Resistant TuberculosisClinical Infectious Diseases, 1995
- Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genomeBiochemical and Biophysical Research Communications, 1986